Series A startup

Who invested in Soteria Biotherapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$42Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $42MMay 2021
Investors
3
See who backed them

The rounds

  1. May 2021
    Series A$42M

    Source recordedSEC filing: $25M sold, first sale May 2021

Founders and team

From Soteria Biotherapeutics's own website and the SEC filings it signed: 2 on the team.

  • Steven JamesBoard Chair
  • Zachary M HillExecutive Officer, Directori

On the board, as filediDavid M AllisonDavid M MorrisKeno M GutierrezMomo M WuNisha M MaratheSteve M James

Everyone who backed them

5AM VenturesVC firm1round
NovartisVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Soteria Biotherapeutics

Who invested in Soteria Biotherapeutics?

Soteria Biotherapeutics's investors include 5AM Ventures, Alexandria Venture Investments and Novartis.

How much has Soteria Biotherapeutics raised?

Soteria Biotherapeutics has raised $42M across 1 round since 2021.

When did Soteria Biotherapeutics last raise?

Soteria Biotherapeutics's most recent round was a Series A of $42M in May 2021.

What was Soteria Biotherapeutics's biggest round?

Its most recent round, $42M in May 2021, is also its largest on record.

Who backed Soteria Biotherapeutics first?

Soteria Biotherapeutics's first round on record, in May 2021, was backed by 5AM Ventures, Alexandria Venture Investments and Novartis.

What stage is Soteria Biotherapeutics at?

Soteria Biotherapeutics's latest named round is a Series A, in May 2021.

Companies like Soteria Biotherapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.